cro.directory
← Compare landing

BioAscent Discovery vs TRiCBIO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBioAscent DiscoveryTRiCBIO
SummaryBioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally.TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Flow Cytometry Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Indications
  • Immunology
  • Neurology
  • Oncology
  • Immunology
  • Rare Disease
  • Gastroenterology
Phases
  • Discovery
  • Discovery
  • Preclinical (General)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Newhouse, Scotland, UK
  • Nanjing, Nanjing, China
  • Shanghai, Shanghai, China
  • Philadelphia, Philadelphia, Pennsylvania, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

BioAscent Discovery alternatives · TRiCBIO alternatives

Markdown mirror: /compare/bioascent-discovery/tricbio.md